Last updated July 12, 2026
Key finding
52.2% of blood glucose measurements were within the target range.
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Short-Term (≤3 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the use of insulin degludec and insulin aspart guided by a clinical decision support system for glycemic control in hospitalized patients with type 2 diabetes, finding a significant percentage of blood glucose measurements within target range.
Effective glycemic control in hospitalized patients with type 2 diabetes is crucial to prevent complications and improve recovery outcomes. This study highlights the potential of using a clinical decision support system to optimize insulin therapy, which can lead to better management of blood glucose levels in a hospital setting, ultimately enhancing patient care.
The study design was non-randomized, which may introduce bias. Results may not be generalizable to all hospitalized patients with diabetes. Limited follow-up duration may not capture long-term effects.
Published in
Publication details and source links for this paper.
Felix A, Daniel AH, Petra MB, et al. Glycemic Control Using Insulin Degludec and Insulin Aspart Guided by a Clinical Decision Support System in Hospitalized Patients with Type 2 Diabetes. Biosensors. 2026;16(5):289. doi:10.3390/bios16050289
52.2% of blood glucose measurements were within the target range.
Mean blood glucose decreased from 11.9 ± 4.4 mmol/L to 7.5 ± 1.9 mmol/L after 6 days.
Adherence to insulin dosing recommendations was 94.2%.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to Insulin therapy and Adherence to insulin dosing recommendations, Blood glucose, Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L, and 1 more.
This study contributes evidence to
Primary intervention
Insulin therapy
Primary outcomes
Evidence topics
Primary intervention
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
2
Related topics
4
Evidence pairs
184
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence relationship
Related evidence
Evidence topic
Save evidence
Evidence topic
Save evidence
Core evidence
The primary outcomes reported in this study.
Insulin therapy → Adherence to insulin dosing recommendations
Insulin therapy → Adherence to insulin dosing recommendations
Insulin therapy → Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L
Insulin therapy → Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L
Insulin therapy → Percentage of hypoglycemic events
Insulin therapy → Percentage of hypoglycemic events
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on Insulin Therapies and Adherence to insulin dosing recommendations, Insulin Therapies and Fasting Glucose.
This study contributes to the evidence on the following intervention-outcome relationships.
Medications
Curated evidence collections and hubs this study is part of.
All studies measuring Adherence to insulin dosing recommendations
Measures Adherence to insulin dosing recommendations as a key outcome.
All studies measuring Fasting Glucose
Measures Fasting Glucose as a key outcome.
All studies on Insulin Therapies
Contributes to Insulin Therapies evidence base.
Latest published studies
Published within the last 2 years.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
Insulin Therapies appears to improve Fasting Glucose.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Blood glucose
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on 5 supporting studies with consistent results and a positive effect signal.
Limitations
Insulin therapy appears to improve Adherence to insulin dosing recommendations.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Adherence to insulin dosing recommendations
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Insulin therapy appears to improve Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Percentage of blood glucose measurements within target range of 3.9–7.8 mmol/L
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of Insulin therapy for Percentage of hypoglycemic events.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Percentage of hypoglycemic events
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
